|
|
Article: Irish Medical Conference Considers Viability of Drug Eluting Stents; Experts To Address This Issue and Others at Upcoming MEDTEC Ireland Event.
- Article from:
- Business Wire
- Article date:
- July 22, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
MEDTEC Ireland 2002
LOS ANGELES--(BUSINESS WIRE)--July 22, 2002
In recent weeks, much attention has been focused upon drug eluting stents and the promise they hold for reduced incidence of restenosis (return of the arterial blockage) after angioplasty. The impact of drug eluting stents on the worldwide coronary stent market -- and the interventional revascularization market as a whole -- could be dramatic. If drug eluting stents "work", the lower incidence of restenosis could make the procedure available to more patients, including many whose only option had previously been invasive bypass surgery. This ...